Abstract B48: Cancer Stem Cells: characteristics, roles in metastatic disease and targeting therapy for the medically underserved

• Published in: Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2017-02, Vol.26 (2_Supplement), p.B48-B48
• Main Authors: Morgatskaya, Zhenya, Mokhtari, Reza Bayat, Tyker, Albina, Kazemi, Parandis, Homayouni, Tina, Baluch, Narges, Dhalla, Sara, Rekhi, Shreya, Kumar, Sushil, Yeger, Herman
• Format: Article
• Language: English
• ISSN: 1055-9965; 1538-7755
• DOI: 10.1158/1538-7755.DISP16-B48

Cancer stem cells have been observed to lead to the proliferation and relapse of cancers. While they share many properties with normal stem cells, CSCs are distinguished by their incredibly high survivability, drug resistance, and the ability to facilitate tumor progression. In this review, we discuss the origin, major properties used to identify and characterize CSCs, and also how they behave and are regulated with tumor progression and metastasis. In addition, we discuss multiple therapeutic strategies that were developed to target CSCs. Amongst these we review several natural compounds that in recent studies have shown great potential for preventing tumorigenesis and in the treatment of cancer cells by interacting with CSCs. Natural compounds are being widely researched for efficacy as cancer and CSC targeting agents. Natural drugs consume much less funding to produce. Also, as dietary compounds, they are less stigmatized by patients than artificially synthesized drugs, and they are inexpensive and available to even the medically underserved. Finally, we discuss several strategies that are used to maximize the effect of therapeutic strategies on the CSC fraction and further directions for this field of tumor biology. Note: This abstract was not presented at the conference. Citation Format: Zhenya Morgatskaya, Reza Bayat Mokhtari, Albina Tyker, Parandis Kazemi, Tina Homayouni, Narges Baluch, Sara Dhalla, Shreya Rekhi, Sushil Kumar, Herman Yeger. Cancer Stem Cells: characteristics, roles in metastatic disease and targeting therapy for the medically underserved. [abstract]. In: Proceedings of the Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2016 Sep 25-28; Fort Lauderdale, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2017;26(2 Suppl):Abstract nr B48.